BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stern S, Linker S, Vadodaria KC, Marchetto MC, Gage FH. Prediction of response to drug therapy in psychiatric disorders. Open Biol. 2018;8. [PMID: 29794033 DOI: 10.1098/rsob.180031] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Kappel DB, Legge SE, Hubbard L, Willcocks IR, O’connell KS, Smith RL, Molden E, Andreassen OA, King A, Jansen J, Helthuis M, Owen MJ, O’donovan MC, Walters JT, Pardiñas AF. Genomic stratification of clozapine prescription patterns using schizophrenia polygenic scores. Biological Psychiatry 2022. [DOI: 10.1016/j.biopsych.2022.07.014] [Reference Citation Analysis]
2 de la Salle S, Shah U, Hyde M, Baysarowich R, Aidelbaum R, Choueiry J, Knott V. Synchronized Auditory Gamma Response to Frontal Transcranial Direct Current Stimulation (tDCS) and its Inter-Individual Variation in Healthy Humans. Clin EEG Neurosci 2022;:15500594221098285. [PMID: 35491558 DOI: 10.1177/15500594221098285] [Reference Citation Analysis]
3 Lamas NJ, Roybon L. Harnessing the Potential of Human Pluripotent Stem Cell-Derived Motor Neurons for Drug Discovery in Amyotrophic Lateral Sclerosis: From the Clinic to the Laboratory and Back to the Patient. Front Drug Discov 2021;1:773424. [DOI: 10.3389/fddsv.2021.773424] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
4 Hongkaew Y, Gaedigk A, Wilffert B, Gaedigk R, Kittitharaphan W, Ngamsamut N, Limsila P, Puangpetch A, Sukprasong R, Sukasem C. Pharmacogenomics Factors Influencing the Effect of Risperidone on Prolactin Levels in Thai Pediatric Patients With Autism Spectrum Disorder. Front Pharmacol 2021;12:743494. [PMID: 34690776 DOI: 10.3389/fphar.2021.743494] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Pardiñas AF, Owen MJ, Walters JTR. Pharmacogenomics: A road ahead for precision medicine in psychiatry. Neuron 2021:S0896-6273(21)00683-8. [PMID: 34619094 DOI: 10.1016/j.neuron.2021.09.011] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
6 Meltzer HY, Gadaleta E. Contrasting Typical and Atypical Antipsychotic Drugs. Focus (Am Psychiatr Publ) 2021;19:3-13. [PMID: 34483761 DOI: 10.1176/appi.focus.20200051] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
7 Lafferty CK, Christinck TD, Britt JP. All-optical approaches to studying psychiatric disease. Methods 2021:S1046-2023(21)00194-8. [PMID: 34314828 DOI: 10.1016/j.ymeth.2021.07.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Freitag CM, Chiocchetti AG, Haslinger D, Yousaf A, Waltes R. [Genetic risk factors and their influence on neural development in autism spectrum disorders]. Z Kinder Jugendpsychiatr Psychother 2021;:1-16. [PMID: 34128703 DOI: 10.1024/1422-4917/a000803] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
9 Korda AI, Andreou C, Borgwardt S. Pattern classification as decision support tool in antipsychotic treatment algorithms. Exp Neurol 2021;339:113635. [PMID: 33548218 DOI: 10.1016/j.expneurol.2021.113635] [Reference Citation Analysis]
10 Cieślik P, Wierońska JM. Regulation of Glutamatergic Activity via Bidirectional Activation of Two Select Receptors as a Novel Approach in Antipsychotic Drug Discovery. Int J Mol Sci 2020;21:E8811. [PMID: 33233865 DOI: 10.3390/ijms21228811] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
11 Bourdon JL, Davies RA, Long EC. Four Actionable Bottlenecks and Potential Solutions to Translating Psychiatric Genetics Research: An Expert Review. Public Health Genomics 2020;23:171-83. [PMID: 33147585 DOI: 10.1159/000510832] [Reference Citation Analysis]
12 Aghabozorg Afjeh SS, Shams J, Hamednia S, Boshehri B, Olfat A, Omrani MD. Investigation of the impact of an ADCY2 polymorphism as a predictive biomarker in bipolar disorder, suicide tendency and response to lithium carbonate therapy: the first report from Iran. Pharmacogenomics 2020;21:1011-20. [PMID: 32893730 DOI: 10.2217/pgs-2020-0058] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Lunenburg CATC, Gasse C. Pharmacogenetics in psychiatric care, a call for uptake of available applications. Psychiatry Res 2020;292:113336. [PMID: 32739644 DOI: 10.1016/j.psychres.2020.113336] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
14 Cuéllar-Barboza AB, McElroy SL, Veldic M, Singh B, Kung S, Romo-Nava F, Nunez NA, Cabello-Arreola A, Coombes BJ, Prieto M, Betcher HK, Moore KM, Winham SJ, Biernacka JM, Frye MA. Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selection. Int J Bipolar Disord 2020;8:23. [PMID: 32632502 DOI: 10.1186/s40345-020-00184-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Maffioletti E, Valsecchi P, Minelli A, Magri C, Bonvicini C, Barlati S, Sacchetti E, Vita A, Gennarelli M. Association study between HTR2A rs6313 polymorphism and early response to risperidone and olanzapine in schizophrenia patients. Drug Dev Res 2020;81:754-61. [DOI: 10.1002/ddr.21686] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
16 Gillett G, Tomlinson A, Efthimiou O, Cipriani A. Predicting treatment effects in unipolar depression: A meta-review. Pharmacol Ther 2020;212:107557. [PMID: 32437828 DOI: 10.1016/j.pharmthera.2020.107557] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
17 González-Rodríguez A, Guàrdia A, Palao DJ, Labad J, Seeman MV. Moderators and mediators of antipsychotic response in delusional disorder: Further steps are needed. World J Psychiatr 2020; 10(4): 34-45 [PMID: 32399397 DOI: 10.5498/wjp.v10.i4.34] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
18 Fernando MB, Ahfeldt T, Brennand KJ. Modeling the complex genetic architectures of brain disease. Nat Genet 2020;52:363-9. [PMID: 32203467 DOI: 10.1038/s41588-020-0596-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
19 Stern S, Sarkar A, Galor D, Stern T, Mei A, Stern Y, Mendes APD, Randolph-Moore L, Rouleau G, Bang AG, Santos R, Alda M, Marchetto MC, Gage FH. A Physiological Instability Displayed in Hippocampal Neurons Derived From Lithium-Nonresponsive Bipolar Disorder Patients. Biol Psychiatry 2020;88:150-8. [PMID: 32278494 DOI: 10.1016/j.biopsych.2020.01.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
20 Sekaran K, M. S. Predicting drug responsiveness with deep learning from the effects on gene expression of Obsessive–Compulsive Disorder affected cases. Computer Communications 2020;151:386-94. [DOI: 10.1016/j.comcom.2019.12.049] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
21 Schmidt-kraepelin C, Feyerabend S, Engelke C, Riesbeck M, Meisenzahl-lechner E, Gaebel W, Verde P, Kolbe H, Correll CU, Leucht S, Heres S, Kluge M, Makiol C, Neff A, Lange C, Englisch S, Zink M, Langguth B, Poeppl T, Reske D, Gouzoulis-mayfrank E, Gründer G, Hasan A, Brockhaus-dumke A, Jäger M, Baumgärtner J, Wobrock T, Cordes J. A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design. Eur Arch Psychiatry Clin Neurosci 2020;270:83-94. [DOI: 10.1007/s00406-019-01063-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Jabbi M, Nemeroff CB. Convergent neurobiological predictors of mood and anxiety symptoms and treatment response. Expert Rev Neurother 2019;19:587-97. [PMID: 31096806 DOI: 10.1080/14737175.2019.1620604] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Francescangeli J, Karamchandani K, Powell M, Bonavia A. The Serotonin Syndrome: From Molecular Mechanisms to Clinical Practice. Int J Mol Sci 2019;20:E2288. [PMID: 31075831 DOI: 10.3390/ijms20092288] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 11.3] [Reference Citation Analysis]
24 Gordon JA, Frost Bellgowan JA, Lawhorn C, Scheinert RB. Challenges and Opportunities in Psychiatric Neuroscience. Cold Spring Harb Symp Quant Biol 2019;83:1-8. [DOI: 10.1101/sqb.2018.83.037523] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
25 Silva MC, Haggarty SJ. Human pluripotent stem cell-derived models and drug screening in CNS precision medicine. Ann N Y Acad Sci 2020;1471:18-56. [PMID: 30875083 DOI: 10.1111/nyas.14012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
26 Fornaro M, De Berardis D, Anastasia A, Novello S, Fusco A, Cattaneo CI, Solmi M, Monaco F, Veronese N, Kim Y, de Bartolomeis A. The identification of biomarkers predicting acute and maintenance lithium treatment response in bipolar disorder: A plea for further research attention. Psychiatry Research 2018;269:658-72. [DOI: 10.1016/j.psychres.2018.08.034] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]